Michael R. Mc Mullen Agilent Technologies, Inc. (A) insider trading activity

Michael R. Mc Mullen is CEO and President of AGILENT TECHNOLOGIES, INC.. Currently has a direct ownership of 253,908 shares of A, which is worth approximately $34 Million. The most recent transaction as insider was on Nov 02, 2022, when has been sold 6,775 shares (Common Stock) at a price of $140.61 per share, resulting in proceeds of $952,632. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 254K

0% 3M change

17.08% 12M change

Total Value Held $34 Million

Michael R. McMullen Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 02 2022	SELL Open market or private sale	$952,632 $140.61 p/Share	6,775 Reduced 3.42%	191,358 Common Stock
Nov 02 2022	BUY Exercise of conversion of derivative security	$276,420 $40.8 p/Share	6,775 Added 3.31%	198,133 Common Stock
Oct 26 2022	SELL Open market or private sale	$910,763 $134.43 p/Share	6,775 Reduced 3.42%	191,358 Common Stock
Oct 26 2022	BUY Exercise of conversion of derivative security	$276,420 $40.8 p/Share	6,775 Added 3.31%	198,133 Common Stock
Oct 19 2022	SELL Open market or private sale	$881,495 $130.11 p/Share	6,775 Reduced 3.42%	191,358 Common Stock
Oct 19 2022	BUY Exercise of conversion of derivative security	$276,420 $40.8 p/Share	6,775 Added 3.31%	198,133 Common Stock
Dec 20 2021	SELL Open market or private sale	$18,373,169 $148.82 p/Share	123,459 Reduced 39.24%	191,187 Common Stock
Nov 19 2021	SELL Payment of exercise price or tax liability	$1,231,100 $164.3 p/Share	7,493 Reduced 2.33%	314,646 Common Stock
Nov 17 2021	SELL Payment of exercise price or tax liability	$438,258 $161.54 p/Share	2,713 Reduced 0.84%	322,139 Common Stock
Nov 16 2021	SELL Payment of exercise price or tax liability	$12,184,461 $161.39 p/Share	75,497 Reduced 18.86%	324,852 Common Stock
Nov 16 2021	BUY Grant, award, or other acquisition	$24,584,054 $161.39 p/Share	152,327 Added 27.56%	400,349 Common Stock
Nov 12 2021	SELL Payment of exercise price or tax liability	$2,140,187 $160.88 p/Share	13,303 Reduced 5.09%	248,022 Common Stock
Apr 22 2021	SELL Open market or private sale	$1,222,155 $135.0 p/Share	9,053 Reduced 3.35%	261,105 Common Stock
Apr 13 2021	SELL Open market or private sale	$1,187,995 $132.5 p/Share	8,966 Reduced 3.21%	270,158 Common Stock
Apr 08 2021	SELL Open market or private sale	$1,966,275 $130.26 p/Share	15,095 Reduced 5.13%	279,124 Common Stock
Feb 16 2021	SELL Open market or private sale	$2,699,580 $130.0 p/Share	20,766 Reduced 6.59%	294,219 Common Stock
Feb 02 2021	SELL Open market or private sale	$5,194,358 $123.74 p/Share	41,978 Reduced 11.76%	314,985 Common Stock
Feb 01 2021	SELL Open market or private sale	$2,550,955 $120.26 p/Share	21,212 Reduced 5.61%	356,963 Common Stock
Dec 01 2020	SELL Open market or private sale	$9,925,910 $115.63 p/Share	85,842 Reduced 17.13%	415,347 Common Stock
Nov 19 2020	SELL Payment of exercise price or tax liability	$4,940,919 $108.68 p/Share	45,463 Reduced 8.32%	501,189 Common Stock
Nov 18 2020	SELL Payment of exercise price or tax liability	$858,619 $105.95 p/Share	8,104 Reduced 1.46%	546,652 Common Stock
Nov 17 2020	SELL Payment of exercise price or tax liability	$5,902,229 $109.86 p/Share	53,725 Reduced 8.83%	554,756 Common Stock
Nov 17 2020	BUY Grant, award, or other acquisition	$14,308,276 $109.86 p/Share	130,241 Added 17.63%	608,481 Common Stock
Nov 16 2020	SELL Payment of exercise price or tax liability	$884,917 $110.27 p/Share	8,025 Reduced 1.65%	478,240 Common Stock
Nov 13 2020	SELL Payment of exercise price or tax liability	$1,568,160 $110.17 p/Share	14,234 Reduced 2.84%	486,265 Common Stock

Also insider at

KLAC

KLA CORP Technology

BMY

BRISTOL MYERS SQUIBB CO Healthcare

Director

MRM